Taikangnuo Biotechnology Limited

Taikangnuo Biotech (TKN Biotech) is a digital biomedical company incubated by the Tech300 Angel Fund of City University of Hong Kong. It focuses on AI-based digital solutions for neurobehavioral surveillance and analysis. The company's flagship platform, Animism™, leverages advanced AI models and neuroscience expertise for automated analysis across experimental animals, pets, livestock, and patients. It aims to transform the future of neurobehavioral health with cutting-edge AI technology, empowering a deeper understanding, precise health monitoring, and accurate diagnosis of brain diseases to fundamentally improve animal and patient outcomes. TKN Biotech collaborates with global customers and medical institutions to accelerate research and development in the biomedical field. The company has more than ten automated behavioral analysis modules, covering multiple fields such as experimental animals, pets, livestock, and patients, serving global customers, and cooperating with many medical institutions. The company aims to innovate in the biotechnology sector, contributing to advancements in health and wellness through cutting-edge research and development.